Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · April 24, 2024

Clinical Outcomes of Subcutaneous vs Intravenous Infliximab Maintenance Therapy in Patients With IBD

Inflammatory Bowel Diseases


Additional Info

Disclosure statements are available on the authors' profiles:

Inflammatory Bowel Diseases
One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort Study
Inflamm. Bowel Dis. 2024 Apr 03;30(4)517-528, SN Hong, J Hye Song, S Jin Kim, Y Ha Park, C Wan Choi, J Eun Kim, E Ran Kim, D Kyung Chang, YH Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading